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ABSTRACT: Raman spectroscopy is a powerful tool for investigating chemical composition. Coupling Raman spectroscopy with 
optical microscopy (Raman micro-spectroscopy) and optical trapping (Raman Tweezers) allows microscopic length scales and 
hence femtolitre volumes to be probed. Raman micro-spectroscopy typically uses UV/visible excitation lasers, but many samples 
including organic molecules and complex tissue samples fluoresce strongly at these wavelengths. Here we report the development 
and application of dispersive Raman micro-spectroscopy designed around a near-infrared continuous wave 1064 nm excitation light 
source. We analyse micro-particles (1-5 μm diameter) composed of polystyrene latex and from three real-world pressurised metered 
dose inhalers (pMDIs) used in the treatment of asthma: salmeterol xinafoate (Serevent®), salbutamol sulfate (Salamol®), and ci-
clesonide (Alvesco®). For the first time, single particles are captured, optically levitated and analysed using the same 1064 nm 
laser, which permits a convenient non-destructive chemical analysis of the true aerosol phase. We show that particles exhibiting 
overwhelming fluorescence using a visible laser (514.5 nm) can be successfully analysed with 1064 nm excitation irrespective of 
sample composition and irradiation time. Spectra are acquired rapidly (1-5 min) with a wavelength resolution of 2 nm over a wide 
wavenumber range (500-3100 cm-1). This is despite the microscopic sample size and low Raman scattering efficiency at 1064 nm. 
Spectra of individual pMDI particles compare well to bulk samples and the Serevent pMDI delivers the thermodynamically pre-
ferred crystal form of salmeterol xinafoate. 1064 nm dispersive Raman micro-spectroscopy is a promising technique which could 
see diverse applications for samples where fluorescence-free characterisation is required with high spatial resolution. 
Raman spectroscopy provides a real time, non-invasive 
means to interrogate chemical composition. The wavelengths 
of light scattered by molecules provide information about the 
functional groups present, and in many cases a “molecular 
fingerprint” for a given structure1. 
Combining Raman spectroscopy with optical microscopy 
(Raman micro-spectroscopy) allows microscopic particles and 
droplets to be probed2. However, to investigate microscopic 
samples without the use of immobilising substrates, which 
may perturb their equilibrium and kinetic properties, strategies 
to stably levitate single micron-sized particles have been de-
veloped3,4. Raman micro-spectroscopy of optically trapped 
particles has been used to better understand cloud and aerosol 
chemistry in the atmosphere5,6 and processes occurring in sin-
gle biological cells7. Typically the use of dispersive Raman 
microspectroscopy, rather than FT-Raman spectroscopy, is 
favoured in optical trapping applications where higher sensi-
tivities and lower detector limits are beneficial in the analysis 
of single microparticles. 
A recent application of particular interest is the characterisa-
tion of aerosol drugs from real-world medical inhalers8. Pres-
surised Metered Dose Inhalers (pMDIs) are an effective and 
rapid means of delivering pharmaceuticals to the lungs, and 
are the most commonly used delivery system for treating 
asthma, chronic obstructive pulmonary disease and other res-
piratory diseases9. Raman spectroscopy enables polymorphic 
crystal forms of drugs to be distinguished10, and the uptake of 
water vapour to be monitored on the particle’s journey from 
inhaler to a high humidity “model lung”11. 
Since Raman scattering is a relatively weak process, appli-
cations of Raman spectroscopy typically employ high intensity 
incident radiation from visible, near-UV or near-IR lasers.  
However, many samples of interest contain organic functional 
groups which fluoresce over the detected wavelength range. 
Photochemistry caused by UV/visible excitation sources can 
also lead to the production of fluorescent photoproducts. If 
fluorophores are present, the high intensity laser can result in 
fluorescence which obscures and overwhelms Raman spectral 
features12.  
In general, shorter wavelength excitation is preferable for 
Raman spectroscopy because scattering is strongly wavelength 
dependent, scaling with λ-4. However, autofluoresence also 
generally increases at shorter wavelengths due to increased 
fluorophore excitation. Recent studies have reported problem-
atic fluorescence of pharmaceutical aerosols at a visible exci-
tation wavelength (514.5 nm)8,11. For biological tissue sam-
ples, which contain an abundant mixture of fluorophores, auto-
fluoresence has been reported even in the near-IR (785 and 
830 nm)13–15. Sample substrates such as glass coverslips can 
also cause fluorescence13. 
To overcome this problem in the current study, we perform 
Raman micro-spectroscopy using much lower photon energies 
from a 1064 nm excitation laser. This substantially reduces 
and in many cases entirely eliminates the possibility of fluo-
rescence. Recent developments in detector technology facili-
tate dispersive Raman measurements at these longer wave-
 lengths. Specifically we utilise an InGaAs array detector with 
quantum efficiency values exceeding 60% across a wave-
length range of 950 nm to 1650 nm. 1064 nm dispersive Ra-
man spectroscopy has been used to analyse liver tissue sam-
ples13–15 using a focal spot size of 25 μm, and living photola-
bile cells16 using a pulsed laser source (10 kHz repetition rate, 
30 ns pulse width) with high peak powers. Here we use a con-
tinuous wave 1064 nm laser to both optically trap and interro-
gate single micron-sized particles: polystyrene beads used as 
laboratory standards, and real-world pharmaceutical aerosols 
from pMDIs. We first present spectra for particles collected 
onto coverslips and then substrate-free measurements on opti-
cally levitated aerosols. 
EXPERIMENTAL SECTION  
 Aerosol environmental chamber and materials. 
Particles were introduced into an environmental chamber for 
analysis. The chamber design has been reported previous-
ly11,17. It consists of an aluminium cell with internal dimen-
sions 10 × 2 × 1 cm, with borosilicate glass windows at the top 
and bottom to transmit the optical trapping and Raman laser 
beams (described in section 2.2). The particle was illuminated 
using an LED source (Comar Optics) and an additional win-
dow on the side of the cell enabled brightfield imaging of the 
trapped particle using a CCD camera (Sony XC-ST51CE) 
coupled to an objective lens (Mitutoyo M Plan Apo 20×). 
 
 
Figure 1. Optical setup for the 1064 nm dispersive Raman micro-
spectroscopy of optically trapped particles. L = lens, M = mirror, 
BS = beam splitter, SM = single mode.  
The cell contains inlet and outlet ports connected to Teflon 
tubing (internal diameter 4 mm) to enable introduction of par-
ticles and gases. A series of commercially available pressur-
ised metered dose inhalers (pMDIs) were used to generate 
pharmaceutical aerosols. Salbutamol sulfate (Salamol®, Ivax), 
salmeterol xinafoate (Serevent®, GlaxoSmithKline Group) and 
ciclesonide (Alvesco®, Nycomed GmbH) pMDIs were con-
nected to the chamber inlet tubing via a rubber septum. For 
optical trapping experiments, single particles (1-5 μm) were 
isolated and levitated in the optical trap following pMDI actu-
ation. For coverslip experiments, particles were allowed to 
deposit onto the bottom coverslip following actuation. The cell 
was carefully cleaned between experiments using water and 
methanol (HPLC grade, Sigma). The outlet port was connect-
ed to an exhaust. 
Polystyrene latex (PSL) spheres were also introduced to the 
chamber via a custom-built atomiser. In additional to conven-
tional PSL spheres (2.1 μm, Invitrogen, S37500, Lot 
1129650), spheres containing the fluorescent dye Envy Green 
(3.87 μm, Bangs Laboratories, FS05F, Lot 10755) were used 
to demonstrate fluorescence during Raman spectrum acquisi-
tion in a controlled manner. Envy Green has a peak absorption 
wavelength of 525 nm and a peak emission wavelength of 565 
nm. The fluorescent spheres were not atomised but diluted in 
water and a droplet placed on a clean coverslip prior to trap-
ping a single bead in solution. 
Relative humidity (RH) and temperature were continuously 
monitored via a probe inside the chamber (Sensiron SHT-75). 
Following particle introduction, the chamber RH was main-
tained below 5% using a continuous 0.2 L/min flow of dry 
nitrogen. Experiments were performed in an air-conditioned, 
temperature-controlled lab (20.5 oC). 
Counter-propagating dual beam optical trap. The 
optical trapping strategy has been described previously6,8,18 
and is capable of stably levitating micron-sized solid and liq-
uid particles (including those of non-spherical geometry) for 
hours-days. The trapping beams were generated using a con-
tinuous wave 1064 nm Nd:Yag laser (Ventus, Laser Quantum) 
passed through a beam splitter (Oz optics) and fibre-coupled 
into two single-mode fibres. The laser powers through the top 
and bottom objective lenses were 15 mW and 10 mW respec-
tively. The foci of the lasers were positioned 10 μm apart to 
create a stable trapping volume for particles in the size range 
1-5 μm. 
Raman spectroscopy. Raman spectroscopy was per-
formed with laser wavelengths of 514.5 nm and 1064 nm. The 
apparatus for 514.5 nm Raman spectroscopy has been dis-
cussed previously11. For 1064 nm Raman spectroscopy, com-
bined with optical trapping, a Nd:Yag laser (Laser Quantum, 
Ventus) was used with a measured maximum laser power of 
between 40 and 66 mW at the focus point of the objective 
lenses. The counter-propagating optical trap was configured as 
previously6 but with the modifications, shown in Figure 1, to 
the lower pathway. This reconfiguration, using high-quality 
optical components, was essential to maximise the NIR 
backscattered signal at the spectrograph. The laser beam was 
aligned through two sets of expansion optics (L1 to L4)19, 
reflected from a long-pass razor edge dichroic mirror (Sem-
rock LPD01-1064) and directed through the objective lens 
with a dichroic mirror (Thorlabs, DMSP950). The second di-
chroic mirror allows the sample to be visualised under bright-
field illumination with the laser wavelength blocked from the 
camera using a colour filter (Comar, KG5). However, during 
acquisition of a Raman spectrum the microscope illumination 
was blocked. 
The Raman light scattered from the focal point was collect-
ed and collimated by the objective lens (Mitutoyo, Plan Apo 
NIR, x50 magnification, NA 0.42, working distance 17 mm) 
and directed back along the same optical pathway. An edge 
filter (Thorlabs,  FEL 1100) was placed after the razor edge 
dichroic to transmit only the Raman shifted light above 1100 
nm. The beam was then focussed through the entrance slit 
(width 100 μm) of a spectrograph (Acton Research Company, 
Isoplane SCT-320) and dispersed onto an InGaAs (640x512) 
array detector (Princeton Instruments, NIRvana 640, 20 μm 
pixels) with a 150 g/mm grating blazed at 1.2 μm. The spectral 
resolution for this configuration is stated by the manufacturer 
as 1.95 nm. Calibration of the spectrometer was performed 
using a Penray lamp (Hg) and verified by acquiring a Raman 
 spectrum from a sample vial of toluene (Aldrich, Spectroscop-
ic grade). Recorded peak positions for toluene were accurate 
to 1.6 rel. cm-1. No corrections were made to the spectral in-
tensity other than background subtraction inherent in the 
Princeton Instruments’ LightField 4 control software. The 
efficiency of the InGaAs array detector decreases above 1.5 
μm such that the CH stretching region was of relatively low 
intensity.  
The conditions for signal acquisition were as follows: For 
samples on cover slips the 1064 nm laser power was 50 mW 
as measured at focus and the spectra were collected for a total 
of 50 seconds for all pMDI formulations. For the Envy Green 
fluorescent beads the power was 50 mW and the acquisition 
time was 10 seconds. For optically levitated pMDI particles of 
salbutamol sulfate and ciclesonide the total power was 40 mW 
and spectra acquired for 300 seconds. For optically trapping of 
salmeterol xinafoate the total power was 66 mW and spectra 
acquired for 140 seconds. For 514.5 nm Raman of the fluores-
cent beads sample, the laser power was 20 mW at focus, spec-
tra acquired for 0.2 seconds, using a 30 μm slit width and a 
600 g/mm grating blazed at 500 nm. The Serevent pMDI par-
ticles shown in Figure 2(b) were continuously acquired with 
an exposure time of 5 seconds per frame and 514.5 nm laser 
power of 4.3 mW at focus. 
For the PSL and coverslip pMDI samples, 1064 nm spectra 
were acquired over three overlapping wavenumber ranges 
(266-1957, 1188-2579 and 2092-3211 cm-1). Overlapping 
regions agreed well and were processed and averaged as de-
scribed below to give the full spectra. Optically trapped pMDI 
spectra were acquired over the low wavenumber range (266-
1957 cm-1) only. 
Data treatment. The intensity of Raman-scattered light is 
inherently weak, and the strong wavelength dependence (λ-4) 
results in a factor of ~ 18 less signal at 1064 nm than 514.5 
nm, so the 1064 nm spectra of single particles were processed 
post-acquisition. A Finite Impulse Response (FIR) filter was 
applied to the raw data using Mathematica v11 (Wolfram) 
using the Lowpass Filter function to remove high-frequency 
noise. Filtering is preferable to techniques such as Savitzky-
Golay (SG) “smoothing” which effectively diminish spectral 
resolution20. A comparison of the raw, FIR-filtered and SG-
smoothed spectra is shown in Figure S1. 
RESULTS AND DISCUSSION  
Wavelength-dependent sample fluorescence. We ex-
emplify the fluorescence problem described in the introduction 
in Figure 2. Figure 2(a) shows spectra of Envy Green dyed 
polystyrene spheres acquired using 514.5 and 1064 nm excita-
tion lasers. The Raman spectral features of the polystyrene are 
not even visible at 514.5 nm due to fluorescence from the dye. 
Envy Green exhibits a broad emission maximum at 565 nm 
which corresponds to the broad peak around 1700 cm-1 in the 
spectrum. By contrast, a fluorescence-free spectrum is ac-
quired at 1064 nm and compares well with literature reports of 
polystyrene beads21. 
 
 
 
Figure 2. (a) Raman spectra of Envy Green-dyed polystyrene 
beads using 514.5 and 1064 nm excitation lasers. The 514.5 nm 
spectrum is offset and scaled to aid comparison with the 1064 nm 
spectrum. Acquisition times were 0.2 and 10 s at 514.5 and 1064 
nm respectively. The spectrum is overwhelmed by fluorescence at 
514.5 nm, but free from fluorescence at 1064 nm. (b) Time-
resolved Raman spectra of an optically trapped salmeterol xina-
foate (Serevent) pMDI particle acquired using a 514.5 nm laser. 
Following exposure to the 514.5 nm laser, sample degradation 
rapidly causes fluorescence and the Raman spectral features are 
obscured within minutes. The spectrum background intensity in-
creases over time due to fluorescence; the spectra are not delib-
erately offset as in (a). 
Figure 2(b) shows spectra for the asthma drug salmeterol 
xinafoate, acquired following different exposure times to a 
514.5 nm excitation laser. The spectrum initially resembles 
previous spectra reported in the literature10, but as noted in 
Davidson et al.11, fluorescence commences almost immediate-
ly following irradiation by the visible laser due to the presence 
of the fluorophore in xinafoic acid. Since one of the key ad-
vantages of optical trapping techniques is the ability to inter-
rogate single particles over long periods of time, photochemi-
cal sample degradation represents a major limitation for sam-
ples containing organic fluorophores. 
  
Figure 3. 1064 nm dispersive Raman spectra acquired for (a) salmeterol xinafoate (Serevent), (b) salbutamol sulfate (Salamol) and (c) 
ciclesonide (Alvesco) pMDI particles collected on the coverslip. None of the samples showed evidence of the fluorescence problems 
demonstrated using a 514.5 nm excitation laser (Figure 2 and Tong et al.8). Major peaks in each spectrum were assigned based on previ-
ous literature and the single-particle spectra here agree well with previous bulk samples. 
 
pMDI particles collected on coverslip. For the re-
mainder of the manuscript we exclusively use 1064 nm excita-
tion to avoid fluorescence and photodegradation. We first re-
port data from pharmaceutical particles collected onto a glass 
coverslip without the added technical complexity of optical 
trapping. This allows us to compare 1064 nm dispersive Ra-
man spectra to previous literature, and assess the fluorescence 
characteristics of particles under these conditions. Raman 
spectra of salmeterol xinafoate, salbutamol sulfate and ci-
clesonide pMDI particles are shown in Figure 3. 
Spectra obtained for all three pharmaceutical aerosols com-
pare very well with previous literature and theoretical predic-
tions10,11,22,23. Major features for salmeterol xinafoate include 
ring stretches (1000, 1022, 1582 and 1620 cm-1), an amine 
stretch (1204 cm-1), a C-O bending mode (1369 cm-1) and C-H 
bending modes (1432 and 1467 cm-1). Salbutamol sulfate 
shows diagnostic peaks corresponding to C-C-O stretching 
(777 cm-1), asymmetric hydroxyl group stretching (975 cm-1), 
C-H bending (1261 cm-1), ring stretching (1445 cm-1) and a 
complex mode related to the phenolic hydroxyl group (1613 
cm-1). Ciclesonide exhibits a dominant peak at 1657 cm-1 cor-
responding to the α,β-unsaturated C=O and others related to 
C-O stretching (1112 cm-1), C-H bending (1300-1470 cm-1)  
 
Figure 4. Comparison of 1064 nm Raman spectra for salmeterol 
xinafoate. Red: a single Serevent pMDI particle (this study). Blue 
and black: bulk powder spectra for two different polymorphs rec-
orded by Ali et al.10. The pMDI particle is consistent with poly-
morph I, and several spectral features highlighting the differences 
between the two polymorphs are marked by shaded bands. 
 and C=C stretching (1600-1620 cm-1). All three spectra show 
expected C-H stretching modes in the region 2850-3100 cm-1, 
although the intensity is diminished by reduced detection of 
NIR light at these wavelengths (>1.5 μm). A detailed assign-
ment of all the spectra in Figure 3 is provided in Tables S1-S3. 
The spectra for all three drugs were consistent irrespective 
of exposure to the 1064 nm laser, and no changes indicative of 
fluorescence could be observed following >1 hour of constant 
exposure. This is advantageous for several reasons: Firstly, 
single particles can in principle be monitored for long time 
periods, including in response to changes in environmental 
parameters such as relative humidity. Secondly, we have con-
firmed that use of this same 1064 nm laser for optical levita-
tion (demonstrated below) is unlikely to cause sample degra-
dation. Finally, longer spectrum integration times could be 
used as a means of compensating for the reduced Raman sig-
nal at longer wavelengths if required. 
Raman spectra provide a sensitive probe not only of molec-
ular structure but also crystal packing. Many crystalline drugs 
exhibit polymorphism, where several stable crystal structures 
can form depending on the conditions during crystal growth. 
Different polymorphs can exhibit differences in properties 
relevant to aerosol drug delivery such as crystal morphology 
and dissolution kinetics24. Ali et al.10 reported spectra for two 
forms of salmeterol xinafoate as bulk powders and distin-
guished them via Raman spectral features. As here, they noted 
that near infrared laser excitation performed better than visible 
excitation in terms of avoiding background fluorescence and 
more clearly identifying and distinguishing the two crystal 
forms. All spectra acquired across a number of Serevent pMDI 
particles in this study match the spectrum for polymorph I as 
shown in Figure 4. 
Characteristic peaks which distinguish the polymorphs are 
indicated on Figure 4. Peaks unique to polymorph I include 
the ring stretch band at 1405 cm-1 and the shoulder at 1597 cm-
1, the ring vibration bands at 1320 and 748 cm-1, the C-H bend-
ing mode at 1346 cm-1 and the in-plane CCN bending mode at 
578 cm-1. Additionally, peaks expected for polymorph II, such 
as the C-H bending mode at 1338 cm-1, are absent. Polymorph 
I is the most thermodynamically stable form at room tempera-
ture and pressure25. We have shown here that it is also the 
form delivered by the Serevent pMDIs following manufacture 
and storage. Micro-spectroscopy of single particles may allow 
the stability and interconversion of polymorphs, and amor-
phous drug preparations, to be assessed with respect to envi-
ronmental parameters such as relative humidity and tempera-
ture. 
 
Figure 5. 1064 nm dispersive Raman spectrum for an optically 
trapped PSL particle. 
Optically levitated particles. Levitation of particles en-
ables unique observations which are not possible if the particle 
resides on the surface of a coverslip. A straightforward exam-
ple is observation of native particle morphology (shape, phase 
separation, mixing state)26. Other measurements become diffi-
cult to replicate for particles deposited on coverslips. For in-
stance, dynamic environmental or physiological changes can 
cause airborne particles to take up a liquid phase (e.g. water), 
forming a core-shell particle or a solution droplet in the pro-
cess. Coverslip measurements of these particles are complicat-
ed by factors such as capillary condensation, surface wettabil-
ity and the contact angle of the liquid with the substrate. This 
 
 
 
 
Figure 6. 1064 nm dispersive Raman spectra for optically trapped 
single particles of (a) salmeterol xinafoate, (b) salbutamol sulfate 
and (c) ciclesonide, from commercial pMDIs. Spectra for parti-
cles deposited on the coverslip (presented in Figure 3) are scaled 
and offset for comparison. 
 can cause unrealistic droplet morphologies to form, as demon-
strated for salbutamol sulfate in Figure S2. Since such mor-
phologies do not have the same surface area and internal capil-
lary pressure as airborne particles, gas-particle equilibria (e.g. 
droplet water content), and the rates of dynamic processes, are 
modified in a non-trivial way. 
Other studies have highlighted that deposition of particles 
on surfaces can result in additional artefacts27,28, for instance 
because the surface acts as a nucleus for phase changes includ-
ing crystallisation. This is particularly relevant for characteris-
ing pharmaceutical aerosols because, as discussed above, most 
drugs can exhibit multiple solid forms with different physico-
chemical properties29. 
While technically more complex, acquisition of spectra in 
the true aerosol phase is therefore desirable. Here we demon-
strate our unique ability to use the same near infrared laser for 
optical levitation and fluorescence-free spectrum acquisition. 
Figure 5 shows a spectrum for an optically trapped PSL parti-
cle over the full wavenumber range. The spectrum shows good 
agreement with previously reported spectra for optically 
trapped PSL particles21. 
Spectra for optically trapped single pMDI particles are also 
shown, in Figure 6. We present spectra for all three pMDI 
drugs, and show the corresponding coverslip spectra presented 
in Figure 3 for reference. We focus on the region between 
500-1800 cm-1 where most of the diagnostic spectral features 
are present. 
There is excellent agreement between the spectra acquired 
for optically trapped particles and those deposited on the co-
verslip in terms of peak positions and relative intensities. The 
spectra of optically trapped particles are slightly noisier than 
corresponding coverslip spectra (where generally larger parti-
cles were analysed than the upper particle size limit imposed 
by optical trapping). If required, this could be compensated for 
by longer integration times as discussed above. Nonetheless, 
we have provided a proof-of-principle demonstration here that 
characteristic spectra of single levitated aerosol particles (1-5 
μm) can be obtained with a relatively short acquisition time 
and without any problematic fluorescence. 
CONCLUSIONS  
1064 nm dispersive Raman micro-spectroscopy has been 
successfully demonstrated for polystyrene latex (PSL) spheres 
and real-world pharmaceutical aerosols from pressurised me-
tered dose inhalers (pMDIs). Spectra have been acquired for 
particles deposited on to a coverslip substrate and for single 
micron-sized particles stably levitated in an optical trap. The 
much lower photon energies associated with excitation at 1064 
nm avoided sample fluorescence which is a common interfer-
ence for materials such as organic solids, minerals and biolog-
ical tissues at shorter wavelengths. 
The strategy presented here probes small (femtolitre) vol-
umes and since spectral acquisition is non-destructive, allows 
acquisition of a sequence of spectra over an extended period of 
time. It is therefore potentially applicable to a wide range of 
samples which are spatially heterogeneous (e.g. 2-dimensional 
“imaging” of biological tissues deposited on a coverslip) or 
which change over time (e.g. the response of an airborne parti-
cle to surface reactions or changes in environmental parame-
ters). 
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